Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis

Table 2

Characteristics of patients.

First author (year)	Number of pts	Etiology of liver disease	Sex (male/female) ()	Age (mean)	Groups	Follow-up (days)	Overall response ()	Complete response ()	No response ()
Sheng (2017)	34	NA	36/32	36.90	XBJ group	7	31	16	3	<0.05
	34	NA			Control group	7	25	10	9
Yuan (2015)	45	NA	36/9	53.50	XBJ group	10	40	25	5	<0.05
	40	NA	32/8	52.30	Control group	10	27	18	13
Wang (2015)	44	NA	23/21	37.85	XBJ group	7	40	27	4	<0.05
	44	NA	22/22	37.92	Control group	7	33	15	11
Zhang (2014)	32	HBV 32	18/14	50.12	XBJ group	28	28	20	4	<0.05
	32		18/14	51.21	Control group	28	22	10	10
Shu (2011)	32	HBV 49; HCV 7; alcohol 5; PBC 3; cryptogenic cirrhosis 2	54/12	33.92	XBJ group	14	28	10	4	<0.05
	34				Control group	14	24	8	10
Zhang (2010)	90	Posthepatitic cirrhosis 73; alcohol 9; PBC 5; cryptogenic cirrhosis 3	62/28	47.20	XBJ group	7	83	8	7	<0.05
	78	Posthepatitic cirrhosis 67; alcohol 7; PBC 3; cryptogenic cirrhosis 1	61/17	48.10	Control group	7	63	2	15
Wang (2010)	30	HBV 36; HCV 5; alcohol 14; PBC 2; unknown origin 3	47/13	51.38	XBJ group	7	28	20	2	<0.05
	30				Control group	7	21	14	9
Jing (2010)	32	NA	23/9	49.30	XBJ group	7	29	22	3	<0.05
	28	NA	21/7	48.70	Control group	7	22	13	6
Gao (2009)	45	NA	38/7	48.30	XBJ group	10	35	25	10	>0.05
	40	NA	35/5	46.20	Control group	10	27	18	13

Pts, patients; XBJ, Xuebijing injection; HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cirrhosis.